Downstream Processing Market by Product (Chromatography Columns and Resins, Filters, Membrane Absorbers, Single-Use Products, and Other Products) and by Technique (Purification, Solid-Liquid Separation, and Clarification/Concentration), by Application (Monoclonal Antibody (MABS) Production, Vaccine Production, Insulin Production, Erythropoietin Production, Immunoglobulin Production, and Other Applications), by End User (Biopharmaceutical Manufacturers and Contract Manufacturing Organizations (CMOs) - Opportunity Analysis and Industry Forecast, 2019-2026

Medical Devices & Supplies	LI_182862	Pages: NA	Jan 2020 \| 1483 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Downstream processing means the recovery and purification of biosynthetic products, mainly pharmaceuticals from natural sources such as plant tissues, animal tissues, or fermentation broth. It is an important stage in the production of pharmaceuticals such as vaccines, hormones (e.g. insulin and human growth hormone), antibodies (e.g. infliximab & abciximab) & antibiotics; enzymes antibodies used in diagnostics; industrial enzymes; flavor and natural fragrance compounds.

The increase in demand for biopharmaceuticals and rise in R&D expenditure for biopharmaceutical companies majorly drive the growth of the market. This is since downstream processing steps play key role in providing quality and pure products. In addition, increased demands for new solutions, process optimization & cost reduction, and growth in use of techniques such as centrifuge to separate biological particles from suspension further fuel the downstream processing market. In contrast, high cost of instruments and the need for skilled professionals restraint the market growth.

This report segments the downstream processing market based on product, technique, application, end user, and region. Based on product, it is categorized into chromatography columns and resins, filters, membrane absorbers, single-use products, and other products. Based on application, it is classified into monoclonal antibody (MAbs) production, vaccine production, insulin production, erythropoietin production, immunoglobulin production, and other applications. In terms of technique, it is divided into purification, solid-liquid separation, and clarification/concentration. Based on end user, it is bifurcated into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the leading manufacturing companies are Thermo Fisher Scientific Inc. (U.S.), General Electric Company (U.S.), Sartorius Stedim Biotech S.A. (France), GlaxoSmithKline (GSK), and Danahar Corporation, Marathon Petroleum Corporation, and Merck KGaA.

Key Benefits

The study provides an in-depth analysis of the global downstream processing market, with current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market by product type assists in understanding the various forms of downstream processing available.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
This report entails the detailed quantitative analysis of the current market and estimations through 20162023, which assists in identifying the prevailing market opportunities.

Downstream Processing Market Key Segmentation:

By Technique

Purification
Solid-liquid separation
Clarification/Concentration

By Product

Chromatography columns and resins
Filters
Membrane Absorbers
Single-use products
Other products (Consumables and Accessories)

By Application

Monoclonal Antibody production
Vaccine production
Insulin production
Immunoglobulin production
Erythropoietin production
Other applications

By End User

Biopharmaceutical manufacturers
Contract Manufacturing Organizations (CMOs)

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com